Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neuromuscular Agents"" wg kryterium: Temat


Tytuł:
Breaking paradigms in the treatment of psoriasis: Use of botulinum toxin for the treatment of plaque psoriasis.
Autorzy:
González C; Dermatology Departament, El Bosque University, Bogotá, Colombia.
Franco M; Dermatology Departament, El Bosque University, Bogotá, Colombia.
Londoño A; Dermatology Departament, CES University, Medellin, Colombia.
Valenzuela F; Faculty of Medicine, University of Chile, Santiago, Chile.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14319. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins, Type A*/adverse effects
Neuromuscular Agents*/adverse effects
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Humans ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Generalized drug eruption with vasculopathic reaction pattern to botulinum toxin injection.
Autorzy:
Gheisari M; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Moslemi Haghighi S; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Baghani M; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bidari-Zerehpoosh F; Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Robati RM; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14294. Date of Electronic Publication: 2020 Sep 21.
Typ publikacji:
Letter
MeSH Terms:
Botulinum Toxins, Type A*/adverse effects
Drug Eruptions*/diagnosis
Drug Eruptions*/etiology
Neuromuscular Agents*
Humans ; Treatment Outcome
Opinia redakcyjna
Tytuł:
Botulinum toxin type A injection in the treatment of acquired symmetrical acrokeratoderma: One case report.
Autorzy:
Chiang CY; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.
Tsai TF; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Dermatology, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14442. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Botulinum Toxins, Type A*/therapeutic use
Neuromuscular Agents*/therapeutic use
Humans ; Skin Diseases/drug therapy
Raport
Tytuł:
An enhanced transcutaneous delivery of botulinum toxin for the treatment of Hailey-Hailey disease.
Autorzy:
Bar-Ilan E; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Koren A; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Shehadeh W; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Mashiah J; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Pediatric Dermatology Unit, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Sprecher E; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Pediatric Dermatology Unit, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Artzi O; Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Pediatric Dermatology Unit, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Dr. Artzi and Associates - Treatment and Research Center, Tel-Aviv, Israel.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Jan; Vol. 33 (1), pp. e13184. Date of Electronic Publication: 2019 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins, Type A/*administration & dosage
Neuromuscular Agents/*administration & dosage
Pemphigus, Benign Familial/*drug therapy
Administration, Topical ; Adult ; Botulinum Toxins, Type A/adverse effects ; Equipment Design ; Female ; Humans ; Male ; Middle Aged ; Neuromuscular Agents/adverse effects ; Pain, Procedural/prevention & control ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The effects/injections of botulinum toxin in chronic migraine headache.
Autorzy:
Kara M; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey.
Kaymak B; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey.
Sekizkardeş M; İstanbul Physical and Rehabilitation Medicine Research and Training Hospital, İstanbul, Turkey.
Özçakar L; Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2018 Jul; Vol. 138 (1), pp. 99.
Typ publikacji:
Letter; Comment
MeSH Terms:
Botulinum Toxins*
Migraine Disorders*
Neuromuscular Agents*
Humans ; Injections
Opinia redakcyjna
Tytuł:
Botulinum toxin for the treatment of depression.
Autorzy:
França K; Department of Dermatology & Cutaneous Surgery, Department of Psychiatry & Behavioral Sciences, Institute for Bioethics & Health Policy, University of Miami Miller School of Medicine, Miami, FL.; Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Universitá Degli Studi 'G. Marconi', Rome, Italy.
Lotti T; Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Universitá Degli Studi 'G. Marconi', Rome, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2017 Mar; Vol. 30 (2). Date of Electronic Publication: 2016 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins/*administration & dosage
Depression/*drug therapy
Neuromuscular Agents/*administration & dosage
Botulinum Toxins/therapeutic use ; Humans ; Neuromuscular Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Autorzy:
Ertzgaard P; Department of Rehabilitation Medicine and Department of Medicine and Health Sciences (IMH), Linköping University Hospital, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Anhammer M; Ipsen, Kista, Sweden.
Forsmark A; Nordic Health Economics AB, Göteborg, Sweden.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2017 Mar; Vol. 135 (3), pp. 366-372. Date of Electronic Publication: 2016 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins, Type A/*therapeutic use
Muscle Spasticity/*drug therapy
Neuromuscular Agents/*therapeutic use
Practice Patterns, Physicians'/*statistics & numerical data
Botulinum Toxins, Type A/economics ; Female ; Humans ; Male ; Muscle Spasticity/economics ; Muscle Spasticity/epidemiology ; Neuromuscular Agents/economics ; Practice Patterns, Physicians'/economics ; Sweden/epidemiology
Czasopismo naukowe
Tytuł:
Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
Autorzy:
Weikamp JG; Radboud University Medical Centre, Donders Centre for Neuroscience (DCN), Department of Rehabilitation/Speech-Language Pathology, Nijmegen, The Netherlands.
Schinagl DA; Radboud University Medical Centre, Department of Radiotherapy, Nijmegen, The Netherlands.
Verstappen CC; Canisius Wilhelmina Ziekenhuis, Department of Neurology, Nijmegen, The Netherlands.
Schelhaas HJ; Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands.
de Swart BJ; Radboud University Medical Centre, Donders Centre for Neuroscience (DCN), Department of Rehabilitation/Speech-Language Pathology, Nijmegen, The Netherlands.
Kalf JG; Radboud University Medical Centre, Donders Centre for Neuroscience (DCN), Department of Rehabilitation/Speech-Language Pathology, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2016 Sep; Vol. 134 (3), pp. 224-31. Date of Electronic Publication: 2016 Jan 25.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Parotid Gland*/drug effects
Submandibular Gland*
Amyotrophic Lateral Sclerosis/*complications
Botulinum Toxins, Type A/*pharmacology
Neuromuscular Agents/*pharmacology
Sialorrhea/*drug therapy
Sialorrhea/*radiotherapy
Aged ; Botulinum Toxins, Type A/administration & dosage ; Female ; Humans ; Injections ; Male ; Middle Aged ; Neuromuscular Agents/administration & dosage ; Pilot Projects ; Prospective Studies ; Sialorrhea/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Cilioretinal artery occlusion and anterior ischaemic optic neuropathy due to periocular botulinum toxin a injection: A case report.
Autorzy:
Ozkahraman Kirik M; Department of Otorhinolaryngology-Head and Neck Surgery, Facial Plastic Surgery, Private Levent Hospital, Istanbul, Turkey.
Arslan E; Department of Neurology, Private Avcilar Baypark Hospital, Istanbul, Turkey.
Kirik F; Faculty of Medicine Department of Ophthalmology, Bezmialem Vakif University, Istanbul, Turkey.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 Feb; Vol. 62 (1), pp. e76-e78. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji:
Case Reports
MeSH Terms:
Botulinum Toxins, Type A/*adverse effects
Neuromuscular Agents/*adverse effects
Optic Neuropathy, Ischemic/*chemically induced
Retinal Artery Occlusion/*chemically induced
Humans ; Optic Nerve/blood supply ; Visual Acuity
Raport
Tytuł:
Infection with Mycobacterium immunogenum following botulinum toxin injection.
Autorzy:
Yeon J; The Skin Hospital, Westmead, NSW, Australia.
Chan RC; Concord Repatriation General Hospital, Concord, NSW, Australia.
Fallah H; Concord Repatriation General Hospital, Concord, NSW, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 Feb; Vol. 62 (1), pp. 79-80. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Botulinum Toxins/*adverse effects
Mycobacteriaceae/*isolation & purification
Mycobacterium Infections/*chemically induced
Neuromuscular Agents/*adverse effects
Skin Diseases, Bacterial/*chemically induced
Adult ; Female ; Humans ; Mycobacterium Infections/microbiology ; Skin Diseases, Bacterial/microbiology
SCR Organism:
Mycobacteroides immunogenum
Raport
Tytuł:
Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.
Autorzy:
Goodman GJ; Monash University, Clayton, Victoria, Australia.
Liew S; Shape Clinic, Darlinghurst, New South Wales, Australia.
Callan P; Private Practice, Geelong, Victoria, Australia.
Hart S; Skin Institute, Remuera, Auckland, New Zealand.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2020 Aug; Vol. 61 (3), pp. 217-225. Date of Electronic Publication: 2020 Mar 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Botulinum Toxins, Type A/*adverse effects
Cosmetic Techniques/*adverse effects
Dermal Fillers/*adverse effects
Hyaluronic Acid/*adverse effects
Neuromuscular Agents/*adverse effects
Consensus ; Contusions/chemically induced ; Contusions/prevention & control ; Directive Counseling ; Edema/chemically induced ; Edema/prevention & control ; Erythema/chemically induced ; Erythema/prevention & control ; Face ; Hematoma/chemically induced ; Hematoma/prevention & control ; Humans ; Injection Site Reaction/etiology ; Injection Site Reaction/prevention & control ; Injections/adverse effects ; Pain/chemically induced ; Pain/prevention & control ; Patient Education as Topic ; Patient Selection
Czasopismo naukowe
Tytuł:
Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
Autorzy:
Hu Y; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Zou L; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.; Department of Rehabilitation, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.
Qi X; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Lu Y; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Zhou X; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Mao Z; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Chen X; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Liu K; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Yang Y; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Wu Z; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Hu Y; Department of Dermatology and Venereology, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.
Ma S; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China.; Department of Clinical Laboratory, The 3rd Affiliated Hospital of Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Jan; Vol. 33 (1), pp. e13181. Date of Electronic Publication: 2019 Dec 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Botulinum Toxins, Type A/*administration & dosage
Neuralgia, Postherpetic/*drug therapy
Neuromuscular Agents/*administration & dosage
Activities of Daily Living ; Aged ; Aged, 80 and over ; Analgesics/administration & dosage ; Female ; Humans ; Injections, Subcutaneous ; Male ; Middle Aged ; Pain Measurement ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A new hypothesis in botulin therapy for depression: Insula cortex modification.
Autorzy:
Cosio T; Dermatologic Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Campione E; Dermatologic Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2019 Sep; Vol. 32 (5), pp. e13008. Date of Electronic Publication: 2019 Jul 08.
Typ publikacji:
Letter
MeSH Terms:
Botulinum Toxins, Type A/*therapeutic use
Brain-Derived Neurotrophic Factor/*biosynthesis
Cerebral Cortex/*drug effects
Depression/*drug therapy
Emotions/*drug effects
Brain-Derived Neurotrophic Factor/drug effects ; Cerebral Cortex/diagnostic imaging ; Cerebral Cortex/metabolism ; Depression/diagnosis ; Depression/metabolism ; Facial Expression ; Humans ; Magnetic Resonance Imaging ; Neuromuscular Agents/therapeutic use
Opinia redakcyjna
Tytuł:
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.
Autorzy:
Campanati A; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Martina E; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Giuliodori K; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Bobyr I; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Consales V; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Offidani A; Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2019 May; Vol. 32 (3), pp. e12841. Date of Electronic Publication: 2019 Feb 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Botulinum Toxins, Type A/*administration & dosage
Hidradenitis Suppurativa/*drug therapy
Neuromuscular Agents/*administration & dosage
Female ; Hidradenitis Suppurativa/diagnosis ; Hidradenitis Suppurativa/physiopathology ; Humans ; Male ; Middle Aged ; Pain/drug therapy ; Pain/etiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study.
Autorzy:
Rasaii S; Dermatology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sohrabian N; Dermatology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Gianfaldoni S; Dermatology, University G. Marconi of Rome, Rome.
Hadibarhaghtalab M; Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pazyar N; Dermatology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Bakhshaeekia A; Plastic Surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Lotti T; Dermatology, University G. Marconi of Rome, Rome, Italy.
Ramirez-Pacheco LA; Jersey State Pain Management Center, Union City, New Jersey.
Lange CS; Radiation Oncology, State University Hospital of New York at Downstate, Brooklyn, New York.
Matta J; Division of Pharmacology and Toxicology, Department of Basic Sciences, Ponce Health Sciences University, Ponce, Puerto Rico.
Seifi V; Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ramirez-Fort MK; Radiation Oncology, Medical University of South Carolina-College of Medicine, Charleston, South C.
Feily A; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2019 Mar; Vol. 32 (2), pp. e12781. Date of Electronic Publication: 2019 Jan 29.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Botulinum Toxins, Type A/*administration & dosage
Glucocorticoids/*administration & dosage
Keloid/*drug therapy
Neuromuscular Agents/*administration & dosage
Triamcinolone Acetonide/*administration & dosage
Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Injections, Intralesional ; Keloid/pathology ; Male ; Pain/drug therapy ; Pain/etiology ; Pilot Projects ; Pruritus/drug therapy ; Pruritus/etiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
The association of tobacco use with prescription of muscle relaxants, benzodiazepines, and opioid analgesics for non-cancer pain.
Autorzy:
Takaki H; Department of Pharmaceutical Health Care and Sciences, Kyushu University Faculty of Pharmaceutical Sciences, Fukuoka, Japan.
Ieiri I; Department of Pharmaceutical Health Care and Sciences, Kyushu University Faculty of Pharmaceutical Sciences, Fukuoka, Japan.
Shibuta H; Department of Life and Welfare Information, Kindai University Kyushu Junior College, Iizuka, Japan.
Onozuka D; Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Hagihara A; Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Pokaż więcej
Źródło:
The American journal on addictions [Am J Addict] 2019 Feb; Vol. 28 (2), pp. 63-70. Date of Electronic Publication: 2019 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Musculoskeletal Pain*/diagnosis
Musculoskeletal Pain*/drug therapy
Musculoskeletal Pain*/epidemiology
Practice Patterns, Physicians'*/standards
Practice Patterns, Physicians'*/statistics & numerical data
Analgesics, Opioid/*therapeutic use
Benzodiazepines/*therapeutic use
Health Care Surveys/*statistics & numerical data
Tobacco Use/*epidemiology
Adult ; Female ; Humans ; Male ; Middle Aged ; Needs Assessment ; Neuromuscular Agents/therapeutic use ; Risk Factors
Czasopismo naukowe
Tytuł:
Botulinum toxin: A review of the mode of action in migraine.
Autorzy:
Do TP; Headache Diagnostic Laboratory, Danish Headache Center and Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Hvedstrup J; Headache Diagnostic Laboratory, Danish Headache Center and Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Schytz HW; Headache Diagnostic Laboratory, Danish Headache Center and Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2018 May; Vol. 137 (5), pp. 442-451. Date of Electronic Publication: 2018 Feb 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Botulinum Toxins, Type A/*therapeutic use
Migraine Disorders/*drug therapy
Neuromuscular Agents/*therapeutic use
Animals ; Humans ; Pain/drug therapy ; Pain Management/methods
Czasopismo naukowe
Tytuł:
Sustained attention in cranial dystonia patients treated with botulinum toxin.
Autorzy:
Allam N; Movement Disorders Unit, Hospital de Base do Distrito Federal, Brasília, DF, Brazil.
Frank JE
Pereira C
Tomaz C
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2007 Sep; Vol. 116 (3), pp. 196-200.
Typ publikacji:
Controlled Clinical Trial; Journal Article
MeSH Terms:
Attention/*drug effects
Botulinum Toxins, Type A/*pharmacology
Cognition/*drug effects
Dystonia/*psychology
Neuromuscular Agents/*pharmacology
Aged ; Botulinum Toxins, Type A/therapeutic use ; Dystonia/drug therapy ; Female ; Frontal Lobe ; Humans ; Male ; Memory/drug effects ; Middle Aged ; Neuromuscular Agents/therapeutic use ; Neuropsychological Tests ; Perception/drug effects
Czasopismo naukowe
Tytuł:
Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
Autorzy:
Cadeddu F; Department of Surgery, Catholic School of Medicine, University Hospital Agostino Gemelli, Rome, Italy.
Bentivoglio AR
Brandara F
Marniga G
Brisinda G
Maria G
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2005 Nov 15; Vol. 22 (10), pp. 997-1003.
Typ publikacji:
Journal Article
MeSH Terms:
Botulinum Toxins, Type A/*therapeutic use
Constipation/*drug therapy
Intestinal Obstruction/*drug therapy
Neuromuscular Agents/*therapeutic use
Parkinson Disease/*complications
Aged ; Aged, 80 and over ; Botulinum Toxins, Type A/administration & dosage ; Constipation/etiology ; Drug Evaluation ; Female ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; Neuromuscular Agents/administration & dosage
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies